Article

Interferometer wins design award

A proprietary interferometer (LipiView Ocular Surface Interferometer, TearScience, Inc.), has received the Medical Design Excellence Award from UBM Canon. The device provides eye-care practitioners with an in-office tear film procedure for dry eye patients that takes less than 5 minutes to perform.

Morrisville, NC-A proprietary interferometer (LipiView Ocular Surface Interferometer, TearScience Inc.), has received the Medical Design Excellence Award from UBM Canon.

The device provides eye-care practitioners with an in-office tear film procedure for patients with dry eye that takes less than 5 minutes to perform.

UBM Canon is a leading business-to-business media company dedicated to the advanced manufacturing sector. The Medical Design Excellence Awards competition recognizes contributions and advances in the design of medical products cleared for marketing by the FDA. Entries are evaluated on the basis of design and engineering features.

“We are honored to receive this distinguished award,” said Tim Willis, chief executive officer and co-founder for TearScience.  “Historically, physicians have had to rely on subjective tests to evaluate dry eye patients. Now, [the interferometer] provides a new, quantifiable alternative for evaluating patients’ tear films. When you consider just how thin a typical tear film is in nanometers, it’s amazing what the [interferometer] can do.”

The interferometer is approved in Canada and Europe; the device has not been cleared for use in the United States by the FDA.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.